Icon to close the modal
Contact Us
Modal Close Icon
Icon to close thank you modal
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
Customer Care
Phone Icon
0800 917 8776

LifeStent™ and LifeStent™ XL Vascular Stent System

Contact Us

Proven performance. The LifeStent™ Vascular Stent is an FDA-approved stent for the SFA and full popliteal artery. 

Long term sustained effectiveness up to three years, and treatment superiority over balloon angioplasty. 

Engineered for bending, compression, and torsion with dynamic vessel conformability. 

Available in 6 mm and 7 mm diameters; and 150 mm to 170 mm in length.

Additionally, the LifeStent™ Solo™ Vascular Stent is available in 6 mm and 7 mm diameters and 200 mm in length.

Features and Benefits
FDA-approved for the SFA and full popliteal artery
Longest lesion length indication (up to 240 mm)1
Unique helical design
Engineered for bending, compression, torsion
Dynamic vessel conformability
Improved lesion coverage with a single stent


1. As of December 2020

2. Laird et al. Nitinol Stent Implantation vs. Balloon Angioplasty for Lesions in the Superficial Femoral and Proximal Popliteal Arteries of Patients With Claudication: Three-Year Follow-up From the RESILIENT Randomized Trial. J Endovasc Ther. 2012;19:1-9. The LifeStent® 5 mm diameter was not included in this trial.

3. RESILIENT I Trial, RESILIENT II Trial, E-TAGIUSS Trial, Retrospective Analysis of LifeStent® Vascular Stent Systems in the Treatment of Long-Segment Lesions, LifeStent® Vascular Stent Delivery System Study (LifeStent® 200 mm Trial),REALITY I Trial,REALITY II Trial, ETAP Trial, CONTINUUM Trial, and RELIABLE Trial. Additional trials ongoing.

Please consult Instructions for Use for product indications for use, contraindications, warnings, precautions, complications, adverse events and detailed safety information.